Effect of Alendronate on Bone in People With Chronic Spinal Cord Injury (SCI) Previously Treated With Teriparatide
Status:
Completed
Trial end date:
2016-08-05
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if a year of alendronate treatment will maintain or
increase bone mass density (BMD) compared to baseline BMD values in people with chronic
spinal cord injury (SCI).
This study will also investigate 1) if alendronate therapy will increase bone strength in
people with chronic SCI, 2) the number of participants with adverse events from alendronate,
and 3) the effects of alendronate on serum markers of bone metabolism.
Phase:
Phase 2
Details
Lead Sponsor:
Northwestern University
Treatments:
Alendronate Antacids Bone Density Conservation Agents Calcium Calcium Carbonate Calcium, Dietary Cholecalciferol Ergocalciferols Teriparatide Vitamin D Vitamins